The 2022 Trauma Webinar Series Part Two: Massive Transfusion in Traumatically Injured Adults and Children

Dartmouth Health Continuing Education for Professionals Home, The 2022 Trauma Webinar Series “ Part Two: Massive Transfusion in Traumatically Injured Adults and Children, 4/5/2022 8:00:00 AM - 4/5/2025 5:00:00 PM,

The need for massive transfusion can occur in patients of any age and may be the result of traumatic injury or other medical or surgical causes. The use of a ratio-based approach is helpful early in the process before laboratory testing becomes available. Once reliable data becomes available, the resuscitation can be tailored to a laboratory-guided approach that provides components the patient needs while preventing unnecessary transfusions. Join us for this session and learn how to recognize the need for massive transfusion in order to provide evidence-based care for adults and children who require this support.

Presenter(s)
Nancy Dunbar, MD 

Presenter Bio
Dr. Dunbar joined the faculty in the Department of Pathology and Laboratory Medicine as a Transfusion Medicine physician in 2010. She has served as the Medical Director of the Blood Bank at Dartmouth-Hitchcock Medical Center since 2012. She is an Associate Professor at the Geisel School of Medicine at Dartmouth. Her research interests include massive transfusion and platelet transfusion safety.  

Learning Outcome(s)
At the conclusion of this learning activity, (at least 75% of) participants will be able to discuss an overview of massive transfusion, including patient management for all ages in need of treatment and how to differentiate the need for fixed ratio versus laboratory guided resuscitation. 

Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**.

Nancy Dunbar, MD, faculty for this learning activity, is a consultant for Verax Biomedical. All of the relevant financial relationships have been mitigated. 

The planning committee members report no financial relationship* with any ineligible companies.**

* A financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Sources
* See slides